Annamaria Gullà

Title: Annamaria Gullà: Innovator in Cancer Treatment

Introduction

Annamaria Gullà is a prominent inventor based in Boston, MA, known for her significant contributions to cancer treatment. With a focus on immunogenic cell death, her work aims to enhance therapeutic strategies for cancer patients.

Latest Patents

Annamaria holds a patent titled "Modulating gabarap to modulate immunogenic cell death." This invention relates to methods of inducing immunogenic cell death to treat cancer in subjects. The approach involves administering a therapeutically effective amount of an agent that increases specific biomarkers in combination with an inducer of immunogenic cell death.

Career Highlights

Annamaria is affiliated with the Dana-Farber Cancer Institute, where she collaborates with leading experts in the field. Her research focuses on innovative methods to improve cancer therapies and patient outcomes.

Collaborations

One of her notable collaborators is Kenneth Carl Anderson, a respected figure in cancer research. Together, they work on advancing the understanding and treatment of cancer through innovative approaches.

Conclusion

Annamaria Gullà's contributions to cancer treatment through her patent and research at the Dana-Farber Cancer Institute highlight her role as a key innovator in the field. Her work continues to pave the way for new therapeutic strategies in oncology.